Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Migraine Clinical Trials

100 recruiting trials for Migraine. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
100
Total Trials
100
Recruiting Now
13
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGPhase 3NCT04965675

A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine

To find out if eptinezumab is better than placebo (normal saline solution) in lowering the number of days with migraine in young people ages 12 to 17 with chronic migraine.

Sponsor: H. Lundbeck A/SEnrolling: 28520 locations
RECRUITINGNCT07347054

Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Shoulder Osteoarthritis(OA)

Chronic musculoskeletal pain (CMP) is a common disease in China, with a high incidence among the elderly, and has a significant impact on patients' quality of life. Shoulder...

Sponsor: Beijing Tiantan HospitalEnrolling: 10361 location
RECRUITINGNCT06628921

The Effectiveness of Eptinezumab During a Migraine Attack (the BE-FREE Study)

A perspective and multicentric study to evaluate the efficacy of eptinezumab administered during a migraine attack. During the intravenous infusion of eptinezumab, some patients...

Sponsor: University of FlorenceEnrolling: 501 location
RECRUITINGPhase 3NCT06241313

Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine

A migraine attack is a moderate or severe headache that usually occurs on one side of the head and is often accompanied by throbbing, sensitivity to light, sensitivity to sound,...

Sponsor: AbbVieEnrolling: 130020 locations
RECRUITINGNCT06953622

Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale

To establish a headache center in China that combines clinical, imaging and laboratory examinations, explore the feasible treatment options for migraine combined with patent...

Sponsor: Peking University Third HospitalEnrolling: 3301 location
RECRUITINGNCT06322407

Ultrasound-guided Stellate Ganglion Block for Treatment of Chronic Migraine in Adult

To assess the 6-months effects and safety of stellate ganglion block(SGB) for Chronic Migraine (CM) patients who failure to undergo preventive therapy and are seeking a more...

Sponsor: Beijing Tiantan HospitalEnrolling: 2061 location
RECRUITINGNCT07267819

Efficacy of Xeomin for Migraines in Patients With Traumatic Brain Injuries vs. Anomalous Health Incidents

This cohort study aims to compare the efficacy of Xeomin injections for migraine management in patients with a history of Traumatic Brain Injury (TBI) versus those with a history...

Sponsor: Uniformed Services University of the Health SciencesEnrolling: 601 location
RECRUITINGNCT07021859

Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptide

Calcitonin gene-related peptide (CGRP) is a key neuropeptide in migraine pathophysiology and treatment. This study investigates whether CGRP administration can trigger aura in...

Sponsor: Danish Headache CenterEnrolling: 211 location
RECRUITINGPhase 2NCT04063540

Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on the Efficacy of Amiloride in the Prophylaxis of...

Recent data suggest involvement of Acid-Sensing Ion Channel channels in the pathophysiology of migraine making these channels a therapeutic target of migraine disease. The...

Sponsor: Centre Hospitalier Universitaire de NiceEnrolling: 405 locations
RECRUITINGPhase 2NCT06602479

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic...

The purpose of this Phase 2 study is to evaluate the safety and efficacy of SC MEDI0618 compared to placebo in participants with episodic migraine.

Sponsor: AbbVieEnrolling: 48820 locations
RECRUITINGNCT07310290

Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome...

Migraine is a neurological disease characterized by moderate or severe headaches, associated with nausea, vomiting, and/or sensitivity to light and sound. This study will assess...

Sponsor: AbbVieEnrolling: 1893 locations
RECRUITINGNCT07103694

i-NEED: NEw migrainE Drugs Database

Approved by the Food and Drug Administration (FDA) and the European Medicine Agency (EMA) starting in 2018, anti-CGRP monoclonal antibodies (anti-CGRP mAbs) represent the first...

Sponsor: IRCCS San Raffaele RomaEnrolling: 26411 location
RECRUITINGPhase 3NCT07040813

The Nordic Chronic Migraine Trial of CGRP Monoclonal Antibody and Onabotulinumtoxin A Dual Therapy Compared to CGRP...

Migraine is characterized by attacks of throbbing, moderate or severe headache, often associated with nausea, vomiting, and/or sensitivity to light and/or sound. Chronic...

Sponsor: Oslo University HospitalEnrolling: 4506 locations
RECRUITINGEarly Phase 1NCT06848166

Study of the Effectiveness and Safety of Embolization of the Middle Meningeal Artery Using Non-adhesive Materials SQUID...

To evaluate the effectiveness and safety of middle meningeal artery (MMA) embolization using non-adhesive materials SQUID 12 and SQUID 18 as a treatment method for patients with...

Sponsor: Vedanta University ClinicEnrolling: 301 location
RECRUITINGNCT07035197

Facilitators and Barriers to Eptinezumab Administration in Thailand

This research study is designed as a longitudinal prospective descriptive study using mixed-method data collection. Eptinezumab, an anti-calcitonin gene-related peptide monoclonal...

Sponsor: Chulalongkorn UniversityEnrolling: 301 location
RECRUITINGPhase 2NCT07304518

Phase II Trial of PRT-064040 Nasal Spray for the Treatment of Migraine in Adults

The purpose of this study is to learn about the efficacy and safety of PRT-064040 Nasal Spray versus placebo in the acute treatment of moderate or severe migraine.

Sponsor: Sichuan Purity Pharmaceutical Technology Co., Ltd.Enrolling: 4561 location
RECRUITINGNCT06372509

A Proteomic Analysis for Understanding the Link Between Migraine and Cardiovascular Disease

This is a multicenter, prospective observational study. Will be collecting data from 90 consecutive patients (aged 25- 60 years ) with and without migraine admitted at our...

Sponsor: Centro Cardiologico MonzinoEnrolling: 901 location
RECRUITINGNCT06398353

Investigating the Impact of Acupuncture on the Quality of Life of Primitive Headaches Patients

Primary headache is one of the most common neurological diseases in modern society, which seriously affects the patient's quality of life. Although the use of painkillers can...

Sponsor: Chang Gung Memorial HospitalEnrolling: 1201 location
RECRUITINGNCT07419607

MIGRAFIT: Evaluating a Group Therapy Program Combining Physical Activity, Progressive Muscle Relaxation and...

Background: Migraine is a headache disorder highly prevalent in children and adolescents. It significantly affects academic performance and quality of life. A conservative...

Sponsor: Medical University InnsbruckEnrolling: 301 location
RECRUITINGNCT06558578

Association of Helicobacter Pylori Infection and Migraine

The study aims to assess the relation between migraine and H pylori infection in children and adolescent.

Sponsor: Sohag UniversityEnrolling: 501 location
RECRUITINGPhase 2NCT05337033

Cannabis for Chronic Headaches in Adolescents: the CAN-CHA Trial

Chronic headaches are a major cause of disability among adolescents. Cannabis products have supported the management of headaches in adults and may play a role in pediatric...

Sponsor: University of ManitobaEnrolling: 203 locations
RECRUITINGNCT06959004

Substance P-Induced Migraine Attacks Without Aura

Substance P is a neuropeptide implicated in the pathogenesis of headache. This study investigates whether its administration can trigger migraine attacks in individuals with...

Sponsor: Danish Headache CenterEnrolling: 211 location
RECRUITINGNCT06409832

RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment

The purpose of this prospective and multicentric study is to evaluate the effectiveness and tolerability of rimegepant as preventive migraine treatment in a cohort of episodic or...

Sponsor: University of FlorenceEnrolling: 1002 locations
RECRUITINGPhase 4NCT04404439

Treatment of Tinnitus With Migraine Medications

Tinnitus represents one of the most common and distressing otologic problems, and it causes various somatic and psychological disorders that interfere with the quality of life. It...

Sponsor: University of California, IrvineEnrolling: 1501 location
RECRUITINGNCT06562413

Searching for Novel Biological Phenotypes in Migraine Patients Resistant to Treatments

The investigators aim to define the neurofunctional phenotype of migraine patients who did not respond to at least 3 preventive treatments, including monoclonal antibodies (mAbs)...

Sponsor: IRCCS National Neurological Institute "C. Mondino" FoundationEnrolling: 1001 location
RECRUITINGPhase 4NCT05582837

Treatment of Meniere's Disease With Migraine Medications

Meniere's disease (MD) is a chronic disease with a variety of fluctuating signs and symptoms, which include vertigo, hearing loss, tinnitus (ringing noise in the ear), aural...

Sponsor: University of California, IrvineEnrolling: 1001 location
RECRUITINGNCT06603558

Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the...

Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound. The study will assess the...

Sponsor: AbbVieEnrolling: 30004 locations
RECRUITINGNCT06450444

The RECLAIM Study.

The purpose of this study is to evaluate the safety and performance, including clinical benefit, of the PRIMUS System for the treatment of Resistant Migraine.

Sponsor: Salvia BioElectronicsEnrolling: 11011 locations
RECRUITINGPhase 4NCT07301008

Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US

Single-center, open label, prospective study conducted at Medstar Georgetown Headache Center. Men and woman ≥ 18 years old that are diagnosed with migraine with or without aura...

Sponsor: Medstar Health Research InstituteEnrolling: 601 location
RECRUITINGNCT07233941

Neuropsychological Profile Characterization in Patients With Migraine: Cognitive Functioning and Psychological Variables

The overall objective is to define the neuropsychological profile of patients with migraine and evaluate its association with: psychological outcome measures (anxiety-depressive...

Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo BestaEnrolling: 1501 location
RECRUITINGEarly Phase 1NCT06464367

Mechanistic Studies of Psilocybin in Headache Disorders

In previous clinical trial work, the investigators observed lasting reductions in headache burden after limited dosing of psilocybin. This purpose of this study is to examine...

Sponsor: Yale UniversityEnrolling: 501 location
RECRUITINGNCT06788977

External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy

This online registry aims to understand the potential benefits and safety of external trigeminal nerve stimulation for the treatment of migraine in pregnant women. Women do not...

Sponsor: Cefaly TechnologyEnrolling: 5501 location
RECRUITINGNCT06409845

Effectiveness and Tolerability of Eptinezumab

The purpose of this prospective and multicentric study is to evaluate the effectiveness and tolerability of eptinezumab as preventive migraine treatment in a cohort of episodic or...

Sponsor: University of FlorenceEnrolling: 1002 locations
RECRUITINGNCT06674772

Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification

Patients will be asked to visit the study center 2 times, the first time for clinical assessment and a second time for sample collection. Healthy controls will only be asked to...

Sponsor: Hospital Universitari Vall d'Hebron Research InstituteEnrolling: 4401 location
RECRUITINGNCT07354126

Comparative Efficacy of Flunarizine and Propanolol in Pediatric Migraine

Flunarizine and propranolol have demonstrated efficacy in reducing migraine frequency across age groups, though evidence in pediatric populations remains limited and inconsistent....

Sponsor: Muhammad Aamir LatifEnrolling: 441 location
RECRUITINGNCT06229834

Chiropractic Care for Episodic Migraine

Migraine, a chronic intermittent headache disorder, ranks in the top five causes of years lived with disability. One promising non-pharmacologic and integrative treatment for...

Sponsor: Brigham and Women's HospitalEnrolling: 601 location
RECRUITINGNCT05769348

Investigation and Modulation of the Central Mu-Opioid Mechanism in Migraine (in Vivo)

This study investigates whether unilateral and bilateral non-invasive brain stimulation, given for 20 minutes/once per day for twenty days (M-F) can reduce migraine pain. Fourty...

Sponsor: University of MichiganEnrolling: 801 location
RECRUITINGNCT06662461

Ultrasound Guided Block of Stellate Ganglion Versus Greater Occipital Nerve in Resistant Migraine and Correlation to...

To investigate the efficacy of Ultrasound guided Stellate Ganglion block in chronic resistant migraine patients in comparison to Greater Occipital Nerve Block correlating its...

Sponsor: Ain Shams UniversityEnrolling: 401 location
RECRUITINGPhase 3NCT06641466

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual...

The purpose of this study is to evaluate the efficacy and safety of rimegepant when administered during the peri-menstrual period (PMP) for intermittent prevention of migraine in...

Sponsor: PfizerEnrolling: 72320 locations
RECRUITINGNCT06503328

Role of Specific microRNAs in Cluster Headache

Cluster headache (CH) is a primary headache included in the trigeminal autonomic cephalalgias (TACs) according to the International Calssification of Headache Disorder, Third...

Sponsor: IRCCS National Neurological Institute "C. Mondino" FoundationEnrolling: 1001 location
RECRUITINGNCT06670053

Puberty, Testosterone, and Brain Development

Transmasculine youth (female sex assigned at birth, male gender identity) who begin clinical gender affirming hormone therapy (GAHT) with testosterone (T) may experience changes...

Sponsor: University of Colorado, DenverEnrolling: 1001 location
RECRUITINGNCT06507150

AI-assisted Migraine Education: Efficacy, Safety and Patients' Acceptance

Migraine affects 1 in 7 people globally, significantly impacting quality of life and economic productivity. Despite its prevalence, limited awareness leads to misdiagnosis,...

Sponsor: Ente Ospedaliero Cantonale, BellinzonaEnrolling: 1401 location
RECRUITINGNCT07028684

Effects of Foot Reflexology Massage in Migraine

Migraine is a primary headache type that usually manifests itself with unilateral, moderate to severe throbbing headaches, often accompanied by symptoms such as nausea, vomiting,...

Sponsor: Karabuk UniversityEnrolling: 201 location
RECRUITINGNCT06938178

High-Density EEG-MEG-wearable EEG: Comparison of Quantitative Electroencephalographic Indicators as Neurophysiological...

Recent studies suggest that Mindfulness may be an effective treatment for migraine, reducing the frequency of attacks, depression, anxiety and improving quality of life. However,...

Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo BestaEnrolling: 401 location
RECRUITINGNCT06461767

Repetitive Transcranial Magnetic Stimulation in Treatment and Prophylaxis of Chronic Migraine in Patients With no...

Compared with the patients with episodic migraine those with chronic migraine have worst quality of life and more severe headache related disability we investigate Repetitive...

Sponsor: Sohag UniversityEnrolling: 601 location
RECRUITINGNCT04628429

CGRP Inhibition, Autonomic Function, and Migraine

The purpose of this clinical study is to better understand the function of the autonomic nervous system in patients with migraine. We aim to understand whether the autonomic...

Sponsor: Medical University of ViennaEnrolling: 1201 location
RECRUITINGNCT05943457

Vitamin K2 Supplementation in Adult Episodic Migraine

Migraine is a debilitating illness and a major cause of disability in the world. It is highly prevalent, especially among women. Vitamin supplementation is a potential therapeutic...

Sponsor: Sola Aoun Bahous, M.D. Ph.D.Enrolling: 1601 location
RECRUITINGPhase 3NCT04743141

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

The purpose of this study is to test the long-term safety of rimegepant in the acute treatment of migraine in children and adolescents (≥ 6 to \< 18 years of age).

Sponsor: PfizerEnrolling: 60020 locations
RECRUITINGNCT06735833

MMA Embolization for Refractory Chronic Migraine

This is a prospective, multi-center, feasibility study to investigate safety and effectiveness of TRUFILL n-BCA liquid embolic system in bilateral middle meningeal artery (MMA)...

Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.Enrolling: 707 locations
RECRUITINGNCT06617832

Trial Designs for Evaluating Migraine Treatment

The study aims to estimate treatment effects in randomized controlled trials (RCT) and a balanced placebo design (BPD) to specify how contextual and psychological factors interact...

Sponsor: University of AarhusEnrolling: 1282 locations

Showing 50 of 100 trials.Search all Migraine trials